Rachel Lutz

By completing the largest ever map of the human genome, researchers believe they are one step closer to understanding diseases.

Patients with multiple sclerosis are influenced by their physicians' relationships with pharmaceutical companies and industry-sponsored clinical trials.

People with HIV are at a lower risk for developing multiple sclerosis, and HIV drugs may slow the progression of MS, according to research from the United Kingdom.

Mental health misdiagnoses are twice as likely for patients from socially disadvantaged groups, according to findings published in Social Psychological and Personality Science.

A drug targeting a bioactive lipid linked to neuropathic pain is pending FDA approval to begin a phase 1 clinical trial.

Secretin stimulated ultrasonography can assess pancreatic fluid flow and can combine with endoscopic short tests to evaluate exocrine pancreatic function, according to research published in the Scandinavian Journal of Gastroenterology.

The National Institute for Health and Care Excellence in United Kingdom has recommended Janssen's Stelara for the treatment of psoriatic arthritis, adding to its recommendation of the drug already to treat plaque psoriasis.

Blood tests to determine severity and existence of brain injury may not be possible due to proteins in the brain, according to a study in the Journal of Neuroscience.

Evaluating the status of lipoprotein may be able to predict a patient's risk for cardiovascular disease for up to 15 years, according to findings in The Journal of the American College of Cardiology.

Electrical pulses targeting the dorsal column were effective in treating Parkinson's disease-like symptoms in mice.

The risk for developing dementia can be predicted using a blood test, according to researchers from Denmark.

Signs of frailty cannot be contributed solely to aging, and may be a combination of sedentary lifestyles and inactivity, according to research.

Researchers believe they can target a receptor protein in the spinal cord to slow nerve damage and paralysis caused by multiple sclerosis.

Treatment with abatacept can help patients with early rheumatoid arthritis maintain remission even after tapering or withdrawing all other therapy, according to research published from Belgium.

Discontinuing disease-modifying anti-rheumatic drug (DMARD) therapy in patients with rheumatoid arthritis who have achieved remission is safe, according to research published in the Annals of Rheumatic Diseases.

Effective, positive communication between patients and their doctors can prevent worsening symptoms, according to research from the University of Exeter.

Lisdexamfetamine dimesylate, a medication approved for ADHD treatment, was assessed for its efficacy in managing binge eating disorder. In some doses, this approach was effective in 4-week binge eating cessation.

New-onset obstructive sleep apnea is related to asthma, according to findings published in JAMA.

Female smokers were the most susceptible to emphysema in a study of male and female smokers and non smokers from Johns Hopkins.

COPD diagnosis is expected to improve in the short term, though physicians must be vigilant in their detection of symptoms in combination with risk factors.

Age is a risk factor for most pulmonary diseases, and new research indicates mitochondrial swelling in the lung cells may be the culprit.

A prototype model of a temporary tattoo like device is able to accurately monitor glucose levels, according to research published in Analytical Chemistry.

Fatigue in multiple sclerosis patients depended on task length in a study published in Frontiers in Neurology.

Rheumatoid arthritis patient care costs can be reduced using the Attribution, Integration, Measurement, Finances and Reporting of Therapies (AIM FARTHER) model developed by researchers at Geisinger Health System in Central Pennsylvania.

Gut and urinary tract infections may prevent rheumatoid arthritis onset, according to research from the Karolinska Institutet.

Contrary to popular opinion, exercise programs may relieve joint and muscle stiffness in patients with rheumatoid arthritis.

The medical marijuana program in Connecticut will expand to cover several additional conditions, including psoriatic arthritis.

In a phase 3 clinical trial, Novartis's drug Gilenya (fingolimod) did not reduce disability in patients with primary progressive multiple sclerosis.

Rheumatoid arthritis can potentially be treated by targeting the super or stretch enhancer regions, according to research results published in Nature.

Treatments for women in pain must differ from men's treatment, and often is, according to a study by the American Society of Anesthesiologists.